Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psychedelic drug
Biotech
Relmada reconsiders plans to test psilocybin for obesity
Relmada’s attempts to see whether a magic mushroom extract could be used to treat obesity may be coming to an end before they really began.
James Waldron
Mar 28, 2025 10:00am
Cybin psychedelic reduces depression severity after 12 months
Nov 18, 2024 12:57pm
Compass delays phase 3 psychedelic data, lays off 30% of staff
Oct 31, 2024 9:00am
Psyence walks away from acquisition of fellow psilocybin biotech
Oct 7, 2024 5:16am
Psyence acquires fellow psilocybin biotech Clairvoyant
Sep 6, 2024 9:25am
PharmAla launches tool aimed at easing access to MDMA drug info
Aug 28, 2024 12:55pm